← Back to declarations

QGEN Qiagen N.V. — dividend yield, history & ex-dividend dates

NYSE· Semi-Annual dividend· Common Stock· ADR · Healthcare / Medical - Diagnostics & Research

$50.33 ▲ $0.16(0.32%) as of Oct 29, 2026 06:20 UTC
Sponsored Advanced charts & data →

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Dividend Snapshot

StatusReduced
Last Dividend$0.3500Paid Jul 14, 2026
Forward Annual$0.35From the $0.3500 dividend declared May 11, 2026
FrequencySemi-Annual
Last Ex-DateJul 07, 2026The most recent ex-dividend date that has already passed.
1-Yr Growth-80.5%Annual totals, 2024–2025

Research Scores

Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.

Dividend Safety Score

84/100

Very strong indicators

Complete data

Dividend Growth Score

46/100

Moderate growth record

Partial data

Dividend Value Score

Not Rated

required input missing: yield history

DividendRank

62/100

Upper middle of the scale

Partial data

How the Dividend Safety Score is built for QGEN
Dividend Safety Score inputs, points and weights
InputValuePointsWeight
Earnings payout ratioEarnings payout ratio 13% (TTM to Jun 30, 2026) 100 20%
FCF payout ratioFCF payout ratio 12% (TTM to Jun 30, 2026) 100 25%
Net debt / EBITDANet debt / EBITDA 1.2x (TTM to Jun 30, 2026) 97 15%
Interest coverageInterest coverage 12.7x (TTM to Jun 30, 2026) 95 10%
Dividend record2 years of uninterrupted regular payments 25 20%
Earnings stabilityNet income positive in 5 of the last 5 fiscal years (FY2021–FY2025) 100 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Growth Score is built for QGEN
Dividend Growth Score inputs, points and weights
InputValuePointsWeight
5-year dividend growthN/A (not used) N/A 25%
Consecutive annual increases0 consecutive annual increases (through 2025) 10 20%
Payout headroomHeadroom from the earnings payout ratio 13% (TTM to Jun 30, 2026) 100 20%
Earnings per share growth (3 years)EPS CAGR -2.1% (FY2022–FY2025) 30 15%
Revenue growth (3 years)Revenue CAGR -0.8% (FY2022–FY2025) 35 10%
10-year dividend growthN/A (not used) N/A 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

Key Metrics

Current Yield

0.70%

At the Oct 29, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$0.3500

Declared May 11, 2026

The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.

Frequency

S Semi-Annual

How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

RSI (14)

73

As of Oct 29, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$32.63 – $55.66

Closes through Oct 23, 2026

The lowest and highest price over the past year, showing where today's price sits in its recent range.

Payout Ratio (TTM)

13.25%

12 months to Jun 30, 2026 (Q2 FY2026)

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

23

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (TTM)

3.10

Price as of Oct 25, 2026; latest reported book value

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is a set of four checks on a dividend's record and the company's data, the same test used across the screener and our ranked lists. Solid: a Dividend Safety Score of 70+ and a yield of 2%+. Accelerating: at least three consecutive completed calendar years of higher total regular dividends. Flawless: since 1990, no calendar year whose total regular dividend fell more than 20% below the year before, and no suspension. Enduring: at least 20 years between the first and latest dividend in our records. All four met earns the S.A.F.E. flag.
S Solid
Below the Solid check (Dividend Safety Score 70+ and yield 2%+): Dividend Safety Score 84/100, yield 0.70%.
A Accelerating
Dividend growth has stalled — 0 consecutive annual increase(s), under the 3 this check looks for.
F Flawless
A calendar year's regular dividend total fell more than 20% below the year before.
E Enduring
23 years of dividend payments on record.

Quote & Key Data

ExchangeNYSEThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume7,144,401Oct 23, 2026 sessionHow many shares changed hands in the trading session dated beside this figure, a rough read on trading activity. Daily bars are refreshed on a slower cycle than the quoted price, so this session can be older than the price above.
Open$50.38Oct 23, 2026 sessionThe price at the start of the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Day Range$50.33 – $50.45Oct 23, 2026 sessionThe lowest and highest price during the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Prev Close$50.22Close of Oct 22, 2026The closing price from the session before the one dated beside these figures.
Market Cap$10.37BAs of Oct 29, 2026The company's total market value (share price times shares outstanding) on the date shown.
Shares Out206.07MImplied by market cap, Oct 29, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (TTM)$1.9812 months to Jun 30, 2026 (Q2 FY2026)Earnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (TTM)25.8Price as of Oct 25, 2026; earnings to Jun 30, 2026Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Last Ex-DateJul 07, 2026Paid Jul 14, 2026The most recent ex-dividend date that has already passed.
Next Ex-DateN/ANone declared yetThe ex-dividend date of the next payment the company has declared, or that is scheduled when no declaration is on file. Future dates our data provider only projects are not shown.

Dividend Growth

3-Yr Growth (CAGR)N/AThe dividend's average annual growth rate over the period, compounded.
5-Yr Growth (CAGR)N/AThe dividend's average annual growth rate over the period, compounded.
Consecutive Increases0 yrsAnnual totals through 2025The number of consecutive years the dividend has increased.

Why the Yield Moved (90 Days)

QGEN's dividend yield fell from 0.83% to 0.70% over the past ~90 days (-0.13 pp). Of that move, +0.00 pp came from changes in the dividend rate and -0.13 pp from the share price ($42.33 on Aug 03, 2026 → $50.33 on Oct 29, 2026). A yield that rises because the price fell is not an improvement in the payout itself.

Yield vs Its Own History

Current0.70%
1-Yr Average3.42%
Low / High0.53% – 11.50%
Percentile27%

Across 272 daily observations over the past 13 months (through Oct 23, 2026), QGEN's current yield is higher than approximately 27% of them. Our stored price history for QGEN covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.3500 S Regular May 11, 2026 Jul 07, 2026 Jul 07, 2026 Jul 14, 2026
$2.2900 S Special N/A Jan 08, 2026 Jan 08, 2026 N/A
$0.2500 S Regular May 07, 2025 Jul 02, 2025 Jul 02, 2025 Jul 10, 2025
$1.2600 A Regular N/A Jan 29, 2025 Jan 29, 2025 Jan 29, 2025
$1.2800 S Regular Jan 22, 2024 Jan 30, 2024 Jan 31, 2024 Jan 31, 2024
$1.0400 I One-off Jan 23, 2017 Jan 25, 2017 Jan 26, 2017 N/A
$0.0281 A One-off N/A Dec 27, 2002 N/A N/A

Peer Comparison

Selected Medical - Diagnostics & Research dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
DHR Danaher Corporation 0.68% 12.2% 9 yrs 78
TMO Thermo Fisher Scientific Inc. 0.27% 14.3% 8 yrs 73
DGX Quest Diagnostics Incorporated 1.40% 7.3% 14 yrs 70
LH Labcorp Holdings Inc. 0.80% N/A 0 yrs 54

QGEN dividend — frequently asked questions

Does Qiagen N.V. pay a dividend?

Yes. Qiagen N.V. (QGEN) currently pays a dividend. The annualized dividend is about $0.35 per share, a yield of approximately 0.70%.

What is Qiagen N.V.'s dividend yield?

Qiagen N.V.'s dividend yield is approximately 0.70%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does Qiagen N.V. pay dividends?

Qiagen N.V. pays dividends semi-annually — 2 times per year.

How long has Qiagen N.V. paid dividends?

Qiagen N.V. has 23 years of dividend payments on record.

Data updated Oct 29, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.